Skip to main content
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
56.47
-0.32 (-0.56%)
May 14, 2025, 10:39 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Therapeutics
130.13M
Log In
Log In
Log In
Therapeutics Growth
68.06%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
United States
96.11M
Log In
Log In
Log In
United States Growth
53.96%
Log In
Log In
Log In
International
34.02M
Log In
Log In
Log In
Germany
-
Log In
Log In
Log In
Other
-
Log In
Log In
Log In